Biotech Co. Plans to Comply with 23andMe’s Current Policies, But What Comes Next?. Biotech firm Regeneron plans to purchase most assets of bankrupt genetics testing firm 23andMe, pending approval from regulators and the bankruptcy court for $256 million. The firm promised to comply with 23andMe’s consumer privacy policies and share its plans for use, privacy and security of data.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/what-does-regenerons-purchase-23andme-mean-for-privacy-a-28437
